ir.coyatherapeutics.comCoya Therapeutics - Investor Relations
ir.coyatherapeutics.com Profile
Ir.coyatherapeutics.com is a subdomain of coyatherapeutics.com, which was created on 2020-10-22,making it 4 years ago.
Discover ir.coyatherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.coyatherapeutics.com Information
| HomePage size: 78.044 KB |
| Page Load Time: 0.134034 Seconds |
| Website IP Address: 162.159.130.11 |
ir.coyatherapeutics.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.coyatherapeutics.com PopUrls
| Coya Therapeutics - Investor Relations https://ir.coyatherapeutics.com/overview/default.aspx |
| News https://ir.coyatherapeutics.com/news/default.aspx |
| Coya Therapeutics - Stock Information https://ir.coyatherapeutics.com/stock-info/default.aspx |
| Governance - Executive Management https://ir.coyatherapeutics.com/governance/executive-management/default.aspx |
| Governance - Committee Composition https://ir.coyatherapeutics.com/governance/committee-composition/default.aspx |
| Governance Documents https://ir.coyatherapeutics.com/governance/governance-documents/default.aspx |
| Resources - Investor Contacts https://ir.coyatherapeutics.com/resources/investor-contacts/default.aspx |
| Events & Presentations https://ir.coyatherapeutics.com/events-and-presentations/default.aspx |
| Financials - SEC Filings https://ir.coyatherapeutics.com/financials/sec-filings/default.aspx |
| Resources - Information Request Form https://ir.coyatherapeutics.com/resources/information-request-form/default.aspx |
ir.coyatherapeutics.com Httpheader
| Date: Mon, 13 May 2024 21:11:58 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 8835a4db3e8e08c6-LAX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Last-Modified: Mon, 13 May 2024 04:07:32 GMT |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
ir.coyatherapeutics.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.cloudflareinsights.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com; img-src data: *.q4cdn.com *.q4web.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="KDUYR-FS1VjL6BpvvAmbOa8IzccMkYS1kDEeHNEXFfk" name="google-site-verification"/ |
| content="7PZC33CdqIbp0gWcZwGxHNtjuQpXcOTuQqGcQxSCY3k" name="google-site-verification"/ |
| content="71rYu7A1airflxtgEpHw4q-iAt7eQiQvMNdzOzeca70" name="google-site-verification"/ |
ir.coyatherapeutics.com Html To Plain Text
Overview News Events & Presentations Stock Information Stock Quote Stock Chart Historical Stock Quote Financials SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Investor Relations Overview News Events & Presentations Stock Information Stock Quote Stock Chart Historical Stock Quote Financials SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Corporate Overview We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. Read More View all news Latest News View all events Latest Events View all presentations Latest Presentation We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. Links SEC Filings Information Request Form IR Contact David Snyder [email protected] Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Coya Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Coya Therapeutics to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings Unsubscribe Email Alert Sign Up Confirmation Terms of Use Privacy Policy © Coya Therapeutics, Inc. All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in new...
ir.coyatherapeutics.com Whois
Domain Name: COYATHERAPEUTICS.COM Registry Domain ID: 2567493011_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-01-12T17:20:01Z Creation Date: 2020-10-22T13:42:22Z Registry Expiry Date: 2027-10-22T13:42:22Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS49.DOMAINCONTROL.COM Name Server: NS50.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:23:07Z <<<